bay 12-8039

Moxifloxacin hydrochloride (BAY12-8039 HCl) is a fourth generation fluoroquinolone with expanded activity against gram-positive bacteria as well as atypical pathogens. Moxifloxacin has been linked to mild ALT elevations during therapy and to rare instances of idiosyncratic acute liver injury with symptoms and jaundice.

Moxifloxacin-d4 hydrochloride (BAY 12-8039-d4) is the hydrochloride salt form of deuterium-labeled Moxifloxacin (Moxifloxacin). This compound acts as an orally effective antibacterial agent and is utilized in research concerning acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and infectious pneumonia.

Moxifloxacin-13C,d3 hydrochloride (BAY 12-8039-13C,d3) is the 13C labeled variant of Moxifloxacin. Moxifloxacin is an orally effective 8-methoxyquinolone compound with antibacterial properties, used in the study of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and infectious pneumonia.

(Rac)-Moxifloxacin ((Rac)-BAY 12-8039 free base) is an isomer of Moxifloxacin Hydrochloride. Moxifloxacin Hydrochloride (BAY 12-8039) is an orally effective 8-methoxyquinolone antibacterial agent used in studies on acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and infectious pneumonia.